Derek Gregory Batcheller
Vorsitzender bei XINTELA AB
Ursprung des Netzwerks ersten Grades von Derek Gregory Batcheller
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden.
34
| Private Company | Investment Managers | 34 |
23
| Public Company | Pharmaceuticals: Major | 23 |
15
| Public Company | Biotechnology | 15 |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden.
10
| Holding Company | Pharmaceuticals: Major | 10 |
| Public Company | Electronic Components | 8 | |
SAGA Diagnostics AB
 SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden.
6
| Holding Company | Medical/Nursing Services | 6 |
ImmuneBiotech Medical Sweden AB
 ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden.
4
| Private Company | Pharmaceuticals: Major | 4 |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022.
4
| Subsidiary | Biotechnology | 4 |
CarryGenes Therapeutics AB
 CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Immodulate Pharma AB
2
| Private Company | 2 | |
Lundoch Diagnostics AB
1
| Private Company | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Derek Gregory Batcheller
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Lund | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Doctorate Degree Doctorate Degree Corporate Officer/Principal Masters Business Admin Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree | |
Adenovir Pharma AB
 Adenovir Pharma AB Pharmaceuticals: MajorHealth Technology Adenovir Pharma AB provides solutions for the treatment of eye diseases. The firm offers treatments and business development opportunities to the pharmaceutical industry. It manufactures antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). The company was founded by Per Niklas Arnberg on December 11, 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Chairman | |
| LIDDS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
| University of Uppsala | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree Masters Business Admin Doctorate Degree Graduate Degree | |
| University of Gothenburg | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Graduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Investor Relations Contact Corporate Officer/Principal Director/Board Member Chief Executive Officer | |
Glactone Pharma AB
 Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Chairman | |
Trophea AB
 Trophea AB Miscellaneous Commercial ServicesCommercial Services Trophea AB provides medical need for a treatment of skin atrophy caused by long-term use of topical glucocorticoids. The company is headquartered in Helsingborg, Sweden. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| AMNIOTICS AB | Biotechnology | Director/Board Member Chief Executive Officer Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Maas Biolab LLC
 Maas Biolab LLC Pharmaceuticals: MajorHealth Technology Maas Biolab LLC manufactures vaccines for chronic neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson's, and Alzheimer's. The American company was founded by Marcus Keep and Eskil Elmér, with Marcus Keep serving as CEO since incorporation. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
| Chalmers University of Technology | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Graduate Degree Masters Business Admin | |
| AROCELL AB | Medical Specialties | Founder Chairman Director/Board Member | |
| ACUCORT AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| COMBIGENE AB | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Executive Officer | |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Generic | Director/Board Member Founder Chief Executive Officer | |
Gedea Biotech AB
 Gedea Biotech AB Miscellaneous Commercial ServicesCommercial Services Gedea Biotech AB provides drugs for the treatment of bacterial and fungal diseases. It develops an antibiotic-free treatment for vaginal fungal infections. The company was founded by Olov Arvid Sterner, Ingrid Helena Strevens, Ulf Christian Ellervik, and Sophie Margareta Manner and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member Founder Founder | |
Pharmacia AB /Hillerod Unit/
 Pharmacia AB /Hillerod Unit/ Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pharmacia AB /Hillerod Unit/ is a pharmaceutical company based in Hillerod, Sweden. Pharmacia AB /Hillerod Unit was acquired by Pharmacia AB /Hillerod UnitManagement/ on January 10, 2001. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of Copenhagen | College/University | Director/Board Member Graduate Degree Corporate Officer/Principal | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ACTIVE BIOTECH AB | Biotechnology | Public Communications Contact General Counsel | |
| CLINICAL LASERTHERMIA SYSTEMS AB | Medical Specialties | Director/Board Member Director/Board Member | |
| STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AddBIO AB
 AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
| NEXAM CHEMICAL HOLDING AB | Chemicals: Major Diversified | Director/Board Member Director of Finance/CFO | |
Cell Invent Sweden AB
 Cell Invent Sweden AB Miscellaneous Commercial ServicesCommercial Services Cell Invent Sweden AB is a company based in Lund, Sweden that develops new human disease models based on reprogrammed Alzheimer patient cells. The Swedish company is developing phenotype-based screening methods for drug discovery, drug development, and companion diagnostics development. The company was founded in 2019 by Håkan Toresson, Camilla Orbjörn, Lennart Minthon, Oskar Hansson, and Håkan Toresson has been the CEO since 2019. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| PEPTONIC MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PERSTORP HOLDING AB (PUBL.) | Chemicals: Specialty | Chairman Corporate Officer/Principal | |
Buzzard Pharmaceuticals AB
 Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Airsonett AB
 Airsonett AB Medical DistributorsDistribution Services Airsonett AB is a holding company that is engaged in the research and development of a non-pharmaceutical treatment for asthma. Its product Airsonett is based on temperature controlled Laminar Airflow technology that creates a radically reduced allergen exposure in the breathing zone for treatment of asthma, allergic rhinitis, and atopic eczema. The company was founded by Jan Tommy Lennart Hedberg, Jan Kristensson, and Dan Kristensson in 2000 and is headquartered in Ängelholm, Sweden. | Medical Distributors | Chairman Director/Board Member | |
| RECIPHARM AB (PUBL) | Biotechnology | Director/Board Member Founder | |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Glactone Pharma Development AB | Director/Board Member Chairman | ||
| Lund Life Science Incubator | Chief Executive Officer Chairman | ||
| Stayble AB | Director/Board Member Director/Board Member | ||
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
Cormorant Pharmaceuticals AB
 Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Chief Executive Officer | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Chairman | |
Genagon Therapeutics AB
 Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
| GLYCOREX TRANSPLANTATION AB | Medical Specialties | President Director/Board Member |
Statistik
International
| Schweden | 47 |
| Dänemark | 3 |
| Vereinigte Staaten | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 33 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Process Industries | 3 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 391 |
| Corporate Officer/Principal | 127 |
| Chairman | 112 |
| Chief Executive Officer | 94 |
| Independent Dir/Board Member | 58 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Derek Gregory Batcheller
- Unternehmensverbindungen
